Absci (ABSI) Total Debt (2020 - 2025)
Absci's (ABSI) quarterly Total Debt came in at $12.8 million in Q3 2025, up 494.66% year-on-year from $2.2 million in Q3 2024, and down 0.74% quarter-over-quarter from $12.9 million in Q2 2025.
Absci (ABSI) Total Debt (2020 - 2025) Analysis & Trends
Absci has disclosed Total Debt across 6 years of filings, most recently posting $12.8 million for Q3 2025.
- Total Debt for Q3 2025 came in at $12.8 million, up 494.66% year-over-year; the trailing twelve-month figure through Sep 2025 was $12.8 million (up 494.66% YoY), and the FY2024 annual result was $14.0 million, down 19.55% from the prior year.
- Total Debt came in at $12.8 million for Q3 2025 at Absci, down from $12.9 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $17.4 million in Q4 2023 to a low of $531000.0 in Q1 2022.
- The 5-year median for Total Debt is $6.4 million (2022), against an average of $7.1 million.
- Across the five-year window, Total Debt slumped 76.45% in 2021 and jumped 1254.05% in 2023, its largest moves.
- Absci's Total Debt stood at $1.1 million in 2021, then soared by 610.32% to $8.0 million in 2022, then soared by 118.06% to $17.4 million in 2023, then dropped by 19.55% to $14.0 million in 2024, then fell by 8.51% to $12.8 million in 2025.
- The last three Total Debt figures came in at $12.8 million (Q3 2025), $12.9 million (Q2 2025), and $13.4 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12.82 Mn |
| Jun 30, 2025 | 12.91 Mn |
| Mar 31, 2025 | 13.43 Mn |
| Dec 31, 2024 | 14.01 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Dec 31, 2023 | 17.41 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 6.38 Mn |
| Mar 31, 2023 | 7.19 Mn |
| Dec 31, 2022 | 7.98 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 7.13 Mn |
| Mar 31, 2022 | 531,000.00 |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 3.35 Mn |
| Dec 31, 2020 | 4.77 Mn |